TSRI Scientists Zero in on Treatment for Charcot-Marie-Tooth Disease

Scientists at The Scripps Research Institute (TSRI) have now shown a path to developing treatments for disease subtype CMT2D.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News